机译:Morab-202,一种利用人源化抗人类FRαFarletuzumab和微管靶向剂Eribulin的抗体 - 药物缀合物,具有有效的抗肿瘤活性
Eisai Inc Oncol Business Grp Oncol Biol Labs Dept Biochem Discovery 210 Welsh Pool Rd Exton;
Eisai Inc Eisai AiM Inst Dept Translat Chem Andover MA USA;
Eisai &
Co Ltd Dept Chem Res Tsukuba Ibaraki Japan;
Eisai Inc Eisai AiM Inst Dept Discovery Chem Andover MA USA;
Eisai Inc Oncol Business Grp Oncol Biol Labs Dept Biochem Discovery 210 Welsh Pool Rd Exton;
Eisai Inc Oncol Business Grp Oncol Biol Labs Dept Biochem Discovery 210 Welsh Pool Rd Exton;
Eisai Inc Oncol Business Grp Oncol Biol Labs Dept Preclin Dev Exton PA 19341 USA;
Eisai Inc Oncol Business Grp Oncol Biol Labs Dept Preclin Dev Exton PA 19341 USA;
Eisai Inc Oncol Business Grp Oncol Biol Labs Dept Bioanalyt Dev Exton PA 19341 USA;
Eisai Inc Oncol Business Grp Oncol Biol Labs Dept Bioanalyt Dev Exton PA 19341 USA;
Eisai Inc Oncol Business Grp Oncol Biol Labs Dept Bioanalyt Dev Exton PA 19341 USA;
Eisai Inc Oncol Business Grp Oncol Biol Labs Dept Preclin Dev Exton PA 19341 USA;
Eisai Inc Eisai AiM Inst Dept Translat Chem Andover MA USA;
Eisai Inc Oncol Business Grp Oncol Biol Labs Dept Preclin Dev Exton PA 19341 USA;
Morphotek Inc Dept Discovery Res Exton PA USA;
Eisai Inc Oncol Business Grp Oncol Biol Labs Dept Biochem Discovery 210 Welsh Pool Rd Exton;
机译:Morab-202,一种利用人源化抗人类FRαFarletuzumab和微管靶向剂Eribulin的抗体 - 药物缀合物,具有有效的抗肿瘤活性
机译:IMGN779是一种具有DNA烷基化活性的新型CD33靶向抗体 - 药物缀合物,在AML的模型中表现出有效的抗肿瘤活性
机译:来自Mirvetuximab Soravtansine,叶酸受体α(FRα) - 特征 - 药物缀合物(ADC)的安全性和活性结果,与铂敏感卵巢癌患者的卡铂组合
机译:KTN0182A,抗试剂盒,吡咯唑二氮杂己酮(PBD)抗体药物缀合物(ADC)在体外和体内抗抗肿瘤类型的抗肿瘤活性
机译:Lorvotuzumab mertansine一种靶向CD56的抗体-药物偶联物在人异种移植模型中具有针对小细胞肺癌的有效抗肿瘤活性
机译:Morab-202,利用人源化抗人富氏菌毒素和微管靶向剂Eribulin的抗体 - 药物缀合物具有效力抗肿瘤活性